{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:19:58Z","timestamp":1792153198277,"version":"4.4.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671188"],"award-info":[{"award-number":["81671188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.arr.2021.101359","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T12:57:50Z","timestamp":1620651470000},"page":"101359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["5-Lipoxygenase as an emerging target against age-related brain disorders"],"prefix":"10.1016","volume":"69","author":[{"given":"Mengdie","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengtan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2021.101359_bib0005","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/jcbfm.1991.115","article-title":"Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats","volume":"11","author":"Baba","year":"1991","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.arr.2021.101359_bib0010","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1111\/bph.12665","article-title":"Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7","volume":"171","author":"B\u00e4ck","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2021.101359_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2021.101359_bib0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3171\/jns.1996.85.1.0112","article-title":"Protective effect of the 5-lipoxygenase inhibitor AA-861 on cerebral edema after transient ischemia","volume":"85","author":"Baskaya","year":"1996","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.arr.2021.101359_bib0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","article-title":"Amyloid-beta (A\u03b2) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy body disorders with A\u03b2 pathology","volume":"105","author":"Bassil","year":"2020","journal-title":"Neuron."},{"key":"10.1016\/j.arr.2021.101359_bib0030","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/STROKEAHA.107.491969","article-title":"Genetic variation in members of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke: a replication study in two independent populations","volume":"39","author":"Bevan","year":"2008","journal-title":"Stroke."},{"key":"10.1016\/j.arr.2021.101359_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.arr.2016.09.006","article-title":"Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: an aging effect","volume":"34","author":"Cai","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2021.101359_bib0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.prostaglandins.2015.03.007","article-title":"Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: signaling through the CysLT2 receptor","volume":"120","author":"Capra","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.arr.2021.101359_bib0045","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-3565(25)23086-5","article-title":"5-Lipoxygenase inhibitory activity of zileuton","volume":"256","author":"Carter","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2021.101359_bib0050","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","article-title":"Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation","volume":"15","author":"Chamorro","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2021.101359_bib0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s13311-019-00787-4","article-title":"Early and sustained increases in leukotriene B4 levels are associated with poor clinical outcome inischemic stroke patients","volume":"17","author":"Chan","year":"2020","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.arr.2021.101359_bib0060","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.neurobiolaging.2006.06.007","article-title":"The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old","volume":"28","author":"Chinnici","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101359_bib0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuroscience.2012.10.009","article-title":"Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability","volume":"228","author":"Chou","year":"2013","journal-title":"Neuroscience."},{"key":"10.1016\/j.arr.2021.101359_bib0070","article-title":"Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson\u2019s disease","volume":"83","author":"Chou","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.arr.2021.101359_bib0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ana.22234","article-title":"5-Lipoxygenase as an endogenous modulator of amyloid \u03b2 formation in vivo","volume":"69","author":"Chu","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2021.101359_bib0080","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.ajpath.2010.12.032","article-title":"Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer\u2019s disease transgenic mouse model involvement of \u03b3-secretase","volume":"178","author":"Chu","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2021.101359_bib0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1742-2094-9-127","article-title":"Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer\u2019s disease mouse model","volume":"9","author":"Chu","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.arr.2021.101359_bib0090","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.neurobiolaging.2012.12.009","article-title":"5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5","volume":"34","author":"Chu","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101359_bib0095","first-page":"101","article-title":"Nordihydroguaiaretic acid partially inhibits inflammatory responses after focal cerebral ischemia in rats","volume":"62","author":"Chu","year":"2010","journal-title":"Acta Physiol. Sin."},{"key":"10.1016\/j.arr.2021.101359_bib0100","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.23642","article-title":"5-Lipoxygenase gene transfer worsens memory, amyloid and tau brain pathologies in a mouse model of Alzheimer\u2019s disease","volume":"72","author":"Chu","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2021.101359_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070991","article-title":"Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer\u2019s disease with plaques and tangles","volume":"8","author":"Chu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2021.101359_bib0110","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1460-9568.2004.03613.x","article-title":"Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via cys-LT1 receptors and mitogen-activated protein kinase pathway","volume":"20","author":"Ciccarelli","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2021.101359_bib0115","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.bjp.0704189","article-title":"Production of leukotrienes in a model of focal cerebral ischaemia in the rat","volume":"133","author":"Ciceri","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2021.101359_bib0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jnr.24354","article-title":"Aquaporins in brain edema","volume":"98","author":"Cl\u00e9ment","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.arr.2021.101359_bib0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biopha.2016.03.017","article-title":"Caffeic acid attenuates oxidative stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental dementia in rats","volume":"81","author":"Deshmukh","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2021.101359_bib0130","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1096\/fj.03-0599fje","article-title":"Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes","volume":"18","author":"Di Gennaro","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2021.101359_bib0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0006-8993(90)91060-T","article-title":"Pre- and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the rat","volume":"527","author":"Dirnagl","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2021.101359_bib0140","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/343282a0","article-title":"Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis","volume":"343","author":"Dixon","year":"1990","journal-title":"Nature."},{"key":"10.1016\/j.arr.2021.101359_bib0145","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/cbdd.12874","article-title":"Structure activity relationship of caffeic acid phenethyl ester analogs as new 5-lipoxygenase inhibitors","volume":"89","author":"Doiron","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.arr.2021.101359_bib0150","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1038\/srep03274","article-title":"Cysteinyl leukotrienes regulate endothelial cell inflammatory and proliferative signals through CysLT\u2082 and CysLT\u2081 receptors","volume":"3","author":"Duah","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2021.101359_bib0155","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1164\/ajrccm\/146.5_Pt_2.S51","article-title":"The role of the endothelial cell in leukotriene biosynthesis","volume":"146","author":"Feinmark","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.arr.2021.101359_bib0160","first-page":"3445","article-title":"Animal models of ischemic stroke and their application in clinical research","volume":"9","author":"Fluri","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.arr.2021.101359_bib0165","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1471-4159.2006.03828.x","article-title":"Activation of 5-lipoxygenase after oxygen-glucose deprivation is partly mediated via NMDA receptor in rat cortical neurons","volume":"97","author":"Ge","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2021.101359_bib0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.phrs.2006.11.007","article-title":"Baicalin attenuates oxygen-glucose deprivation-induced injury via inhibiting NMDA receptor-mediated 5-lipoxygenase activation in rat cortical neurons","volume":"55","author":"Ge","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2021.101359_bib0175","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1007\/s12035-017-0817-7","article-title":"Overexpression of 5-lipoxygenase worsens the phenotype of a mouse model of tauopathy","volume":"55","author":"Giannopoulos","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2021.101359_bib0180","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.biopsych.2013.04.009","article-title":"5-Lipoxygenase activating protein reduction ameliorates cognitive deficit, synaptic dysfunction, and neuropathology in a mouse model of Alzheimer\u2019s disease","volume":"74","author":"Giannopoulos","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2021.101359_bib0185","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/mp.2013.23","article-title":"Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer\u2019s disease","volume":"19","author":"Giannopoulos","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2021.101359_bib0190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.biopsych.2015.01.015","article-title":"Pharmacologic inhibition of 5-Lipoxygenase improves memory, rescues synaptic dysfunction and ameliorates tau pathology in a transgenic model of tauopathy","volume":"78","author":"Giannopoulos","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2021.101359_bib0195","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12759","article-title":"Antileukotriene therapy by reducing tau phosphorylation improves synaptic integrity and cognition of P301S transgenic mice","volume":"17","author":"Giannopoulos","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2021.101359_bib0200","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s12035-018-1124-7","article-title":"Learning impairments, memory deficits, and neuropathology in aged tau transgenic mice are dependent on leukotrienes biosynthesis: role of the cdk5 kinase pathway","volume":"56","author":"Giannopoulos","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2021.101359_bib0205","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1139\/y89-073","article-title":"L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor","volume":"67","author":"Gillard","year":"1989","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.arr.2021.101359_bib0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10787-010-0052-6","article-title":"Licofelone attenuates MPTP-induced neuronal toxicity: behavioral, biochemical and cellular evidence","volume":"18","author":"Gupta","year":"2010","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.arr.2021.101359_bib0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2017.07.019","article-title":"Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis","volume":"153","author":"G\u00fcr","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.arr.2021.101359_bib0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.prostaglandins.2019.03.003","article-title":"Beyond leukotriene formation-the noncanonical functions of 5-lipoxygenase","volume":"142","author":"H\u00e4fner","year":"2019","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.arr.2021.101359_bib0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000351096","article-title":"MK886 reduces cerebral amyloid angiopathy severity in TgCRND8 mice","volume":"13","author":"Hawkes","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.arr.2021.101359_bib0230","doi-asserted-by":"crossref","first-page":"18286","DOI":"10.1038\/srep18286","article-title":"Inflammatory eicosanoids increase amyloid precursor protein expression via activation of multiple neuronal receptors","volume":"5","author":"Herbst-Robinson","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2021.101359_bib0235","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2217\/fnl.14.44","article-title":"Animal models of stroke: translational potential at present and in 2050","volume":"9","author":"Herson","year":"2014","journal-title":"Future Neurol."},{"key":"10.1016\/j.arr.2021.101359_bib0240","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2021.101359_bib0245","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/glia.20588","article-title":"Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation","volume":"56","author":"Huang","year":"2008","journal-title":"Glia."},{"key":"10.1016\/j.arr.2021.101359_bib0250","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1742-2094-9-145","article-title":"Transforming growth factor \u03b21-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1","volume":"9","author":"Huang","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.arr.2021.101359_bib0255","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1369\/jhc.2008.951855","article-title":"Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer\u2019s disease","volume":"56","author":"Ikonomovic","year":"2008","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.arr.2021.101359_bib0260","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2021.101359_bib0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-3-12","article-title":"Inhibition of NF-kappa B activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia","volume":"3","author":"Jatana","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.arr.2021.101359_bib0270","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5607\/en.2018.27.2.77","article-title":"Astrocytes, microglia, and Parkinson\u2019s disease","volume":"27","author":"Joe","year":"2018","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.arr.2021.101359_bib0275","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuropharm.2013.06.014","article-title":"Protection of dopaminergic neurons by 5-lipoxygenase inhibitor","volume":"73","author":"Kang","year":"2013","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.arr.2021.101359_bib0280","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0090-6980(88)90011-1","article-title":"Plasma levels of leukotriene C4, B4, slow reacting substance of anaphylaxis in chronological phases of cerebrovascular disease","volume":"36","author":"Katsura","year":"1988","journal-title":"Prostaglandins."},{"key":"10.1016\/j.arr.2021.101359_bib0285","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4162\/nrp.2015.9.5.480","article-title":"Protective role of caffeic acid in an A\u03b225-35-induced Alzheimer\u2019s disease model","volume":"9","author":"Kim","year":"2015","journal-title":"Nutr. Res. Pract."},{"key":"10.1016\/j.arr.2021.101359_bib0290","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0197-4580(02)00021-0","article-title":"Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity","volume":"23","author":"Klegeris","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101359_bib0295","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12031-014-0414-4","article-title":"Effect of licofelone a dual COX\/5-LOX inhibitor in intracerebroventricular streptozotocin-induced behavioral and biochemical abnormalities in rats","volume":"55","author":"Kumar","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.arr.2021.101359_bib0300","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pneurobio.2013.11.006","article-title":"Excitotoxicity and stroke: identifying novel targets for neuroprotection","volume":"115","author":"Lai","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2021.101359_bib0305","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1471-4159.1996.66010147.x","article-title":"Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling","volume":"66","author":"Lammers","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2021.101359_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2008.08.053","article-title":"Phenidone protects the nigral dopaminergic neurons from LPS-induced neurotoxicity","volume":"445","author":"Li","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2021.101359_bib0315","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/jnr.21913","article-title":"Oxygen-glucose deprivation activates 5-lipoxygenase mediated by oxidative stress through the p38 mitogen-activated protein kinase pathway in PC12 cells","volume":"87","author":"Li","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.arr.2021.101359_bib0320","first-page":"45","article-title":"Inhibitory effects of caffeic acid on 5-lipoxygenase activation induced by oxidative stress in PC12 cells","volume":"25","author":"Li","year":"2011","journal-title":"Chin. J. Pharmacol. Toxicol."},{"key":"10.1016\/j.arr.2021.101359_bib0325","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12993-015-0064-x","article-title":"The protective effect of caffeic acid on global cerebral ischemia-reperfusion injury in rats","volume":"11","author":"Liang","year":"2015","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.arr.2021.101359_bib0330","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/bs.apha.2014.07.001","article-title":"Aging, the metabolic syndrome, and ischemic stroke: redefining the approach for studying the blood-brain barrier in a complex neurological disease","volume":"71","author":"Lucke-Wold","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.arr.2021.101359_bib0335","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.2133253100","article-title":"Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity","volume":"100","author":"Luo","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2021.101359_bib0340","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2174\/1389450120666190214115309","article-title":"Targeting water in the brain: role of aquaporin-4 in ischemic brain edema","volume":"20","author":"Mamtilahun","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.arr.2021.101359_bib0345","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.mehy.2005.09.031","article-title":"5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer\u2019s disease","volume":"66","author":"Manev","year":"2006","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.arr.2021.101359_bib0350","first-page":"1464","article-title":"Putative role of neuronal 5-lipoxygenase in an aging brain","volume":"14","author":"Manev","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2021.101359_bib0355","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1038\/ncomms9466","article-title":"Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug","volume":"6","author":"Marschallinger","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2021.101359_bib0360","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/j.neurobiolaging.2014.05.016","article-title":"Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer\u2019s disease mice","volume":"35","author":"Meco","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101359_bib0365","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s40478-020-00989-4","article-title":"Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer\u2019s disease mice","volume":"8","author":"Michael","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2021.101359_bib0370","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1126\/science.6719118","article-title":"Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusion","volume":"224","author":"Moskowitz","year":"1984","journal-title":"Science."},{"key":"10.1016\/j.arr.2021.101359_bib0375","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.6753151","article-title":"The 1982 nobel prize in physiology or medicine","volume":"218","author":"Oates","year":"1982","journal-title":"Science."},{"key":"10.1016\/j.arr.2021.101359_bib0380","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ana.410240411","article-title":"The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat","volume":"24","author":"Park","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2021.101359_bib0385","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2013.12.071","article-title":"The dual role of astrocyte activation and reactive gliosis","volume":"565","author":"Pekny","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2021.101359_bib0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100966","article-title":"Is Alzheimer\u2019s disease an inflammasomopathy?","volume":"56","author":"Pereira","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2021.101359_bib0395","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/FBP.0000000000000076","article-title":"Caffeic acid protects mice from memory deficits induced by focal cerebral ischemia","volume":"25","author":"Pinheiro Fernandes","year":"2014","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.arr.2021.101359_bib0400","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.arr.2021.101359_bib0405","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbalip.2014.08.012","article-title":"5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease","volume":"1851","author":"R\u00e5dmark","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.arr.2021.101359_bib0410","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1023\/A:1020916905312","article-title":"Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils","volume":"24","author":"Rao","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2021.101359_bib0415","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/BF01133779","article-title":"From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes","volume":"3","author":"Samuelsson","year":"1983","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.arr.2021.101359_bib0420","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.arr.2021.101359_bib0425","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2016.01.022","article-title":"Arachidonate 5-lipoxygenase (ALOX5) gene polymorphism is associated with Alzheimer\u2019s disease and body mass index","volume":"362","author":"\u0160er\u00fd","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2021.101359_bib0430","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1007\/s12035-017-0527-1","article-title":"5-LOX in Alzheimer\u2019s disease: potential serum marker and in vitro evidences for rescue of neurotoxicity by its inhibitor YWCS","volume":"55","author":"Shekhar","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2021.101359_bib0435","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2174\/1567202612666150812150606","article-title":"The 5-lipoxygenase (5-LOX) inhibitor zileuton reduces inflammation and infarct size with improvement in neurological outcome following cerebral ischemia","volume":"12","author":"Silva","year":"2015","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.arr.2021.101359_bib0440","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1016\/j.bmc.2019.06.040","article-title":"5-Lipoxygenase as a drug target: a review on trends in inhibitors structural design, SAR and mechanism based approach","volume":"27","author":"Sinha","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.arr.2021.101359_bib0445","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7150\/ijms.18025","article-title":"Parkinson\u2019s disease might increase the risk of cerebral ischemic lesions","volume":"14","author":"Song","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.arr.2021.101359_bib0450","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/imm.12922","article-title":"Inflammation in CNS neurodegenerative diseases","volume":"154","author":"Stephenson","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.arr.2021.101359_bib0455","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-2202-13-146","article-title":"Disruption of the alox5ap gene ameliorates focal ischemic stroke: possible consequence of impaired leukotriene biosynthesis","volume":"13","author":"Str\u00f6m","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.arr.2021.101359_bib0460","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2012.08.026","article-title":"Leukotriene D4 induces cognitive impairment through enhancement of CysLT\u2081 R-mediated amyloid-\u03b2 generation in mice","volume":"65","author":"Tang","year":"2013","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.arr.2021.101359_bib0465","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejphar.2011.09.171","article-title":"Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice","volume":"670","author":"Tsai","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2021.101359_bib0470","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s10753-010-9191-6","article-title":"Zileuton reduces inflammatory reaction and brain damage following permanent cerebral ischemia in rats","volume":"33","author":"Tu","year":"2010","journal-title":"Inflammation."},{"key":"10.1016\/j.arr.2021.101359_bib0475","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s11064-016-1994-x","article-title":"5-LOX inhibitor zileuton reduces inflammatory reaction and ischemic brain damage through the activation of PI3K\/Akt signaling pathway","volume":"41","author":"Tu","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2021.101359_bib0480","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2021.101359_bib0485","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1096\/fasebj.12.6.439","article-title":"Aging-associated up-regulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability","volume":"12","author":"Uz","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2021.101359_bib0490","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41398-017-0017-2","article-title":"The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy","volume":"7","author":"Vagnozzi","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2021.101359_bib0495","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12695","article-title":"Brain 5-lipoxygenase over-expression worsens memory, synaptic integrity, and tau pathology in the P301S mice","volume":"17","author":"Vagnozzi","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2021.101359_bib0500","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-2999(93)90844-8","article-title":"Protection from hypoxic and Nmethyl-D-aspartate injury with azelastine, a leukotriene inhibitor","volume":"238","author":"Wallis","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2021.101359_bib0505","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbrc.2006.09.057","article-title":"Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression","volume":"350","author":"Wang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2021.101359_bib0510","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neuint.2013.01.002","article-title":"Leukotriene D4 induces amyloid-\u03b2 generation via CysLT(1)R-mediated NF-\u03baB pathways in primary neurons","volume":"62","author":"Wang","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2021.101359_bib0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2019.12.013","article-title":"Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: Implications for cerebral ischemia and neurodegenerative diseases","volume":"87","author":"Wang","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101359_bib0520","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/aps.2013.130","article-title":"Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro","volume":"35","author":"Yu","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.arr.2021.101359_bib0525","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1254\/jphs.08321FP","article-title":"Leukotriene D4 stimulates the migration but not proliferation of endothelial cells mediated by the cysteinyl leukotriene cyslt(1) receptor via the extracellular signal-regulated kinase pathway","volume":"109","author":"Yuan","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.arr.2021.101359_bib0530","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharep.2018.08.004","article-title":"Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: relevance to Parkinson\u2019s disease therapy","volume":"71","author":"Zaitone","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.arr.2021.101359_bib0535","first-page":"150","article-title":"5-lipoxygenase is involved in rotenone-induced injury in PC12 cells","volume":"40","author":"Zhang","year":"2011","journal-title":"Zhejiang Univ. Med. Sci."},{"key":"10.1016\/j.arr.2021.101359_bib0540","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.113.203604","article-title":"HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation","volume":"346","author":"Zhang","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2021.101359_bib0545","first-page":"273","article-title":"Zileuton, a 5-lipoxygenase inhibitor, attenuates mouse microglial cell-mediated rotenone toxicity in PC12 cells","volume":"43","author":"Zhang","year":"2014","journal-title":"Zhejiang Univ. Med. Sci."},{"key":"10.1016\/j.arr.2021.101359_bib0550","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2014.05.026","article-title":"Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1","volume":"1572","author":"Zhang","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2021.101359_bib0555","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1745-7254.2006.00406.x","article-title":"Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats","volume":"27","author":"Zhou","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.arr.2021.101359_bib0560","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.lfs.2006.05.022","article-title":"Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats","volume":"79","author":"Zhou","year":"2006","journal-title":"Life Sci."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163721001069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163721001069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:49:02Z","timestamp":1761590942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163721001069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":112,"alternative-id":["S1568163721001069"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2021.101359","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Lipoxygenase as an emerging target against age-related brain disorders","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2021.101359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101359"}}